Ernexa Therapeutics, Inc. (ERNA)
4.30
+0.14
(+3.24%)
USD |
NASDAQ |
Sep 14, 10:07
Ernexa Therapeutics Price to Book Value : 1.573 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.523 |
| September 10, 2026 | 1.470 |
| September 09, 2026 | 1.470 |
| September 08, 2026 | 1.532 |
| September 04, 2026 | 1.576 |
| September 03, 2026 | 1.657 |
| September 02, 2026 | 1.660 |
| September 01, 2026 | 1.591 |
| August 31, 2026 | 1.671 |
| August 28, 2026 | 1.671 |
| August 27, 2026 | 1.732 |
| August 26, 2026 | 1.788 |
| August 25, 2026 | 1.801 |
| August 24, 2026 | 1.842 |
| August 21, 2026 | 1.778 |
| August 20, 2026 | 1.653 |
| August 19, 2026 | 1.620 |
| August 18, 2026 | 1.554 |
| August 17, 2026 | 1.485 |
| August 14, 2026 | 1.562 |
| August 13, 2026 | 1.573 |
| August 12, 2026 | 1.617 |
| August 11, 2026 | 1.606 |
| August 10, 2026 | 1.657 |
| August 07, 2026 | 1.540 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.595 |
| August 05, 2026 | 1.500 |
| August 04, 2026 | 1.617 |
| August 03, 2026 | 1.262 |
| July 31, 2026 | 1.200 |
| July 30, 2026 | 1.269 |
| July 29, 2026 | 1.247 |
| July 28, 2026 | 1.320 |
| July 27, 2026 | 1.434 |
| July 24, 2026 | 1.437 |
| July 23, 2026 | 1.459 |
| July 22, 2026 | 1.628 |
| July 21, 2026 | 1.660 |
| July 20, 2026 | 1.986 |
| July 17, 2026 | 2.348 |
| July 16, 2026 | 2.604 |
| July 15, 2026 | 2.461 |
| July 14, 2026 | 2.216 |
| July 13, 2026 | 2.026 |
| July 10, 2026 | 2.216 |
| July 09, 2026 | 2.169 |
| July 08, 2026 | 2.096 |
| July 07, 2026 | 2.268 |
| July 06, 2026 | 2.355 |
| July 02, 2026 | 2.293 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cerenome, Inc. | 2.997 |
| ACADIA Pharmaceuticals, Inc. | 3.639 |
| Alnylam Pharmaceuticals, Inc. | 24.48 |
| Anika Therapeutics, Inc. | 2.034 |
| Savara, Inc. | 7.606 |
Price to Book Value Related Metrics
| Price | 4.30 |
| Earnings Yield | -440.1% |
| Market Cap | 5.031M |